SANTA MONICA, Calif.–(BUSINESS WIRE)–Today, GoodRx (Nasdaq: GDRX), the leading prescription savings platform in the U.S., announced the availability of new affordability programs for menopause hormone therapies by Pfizer. Through the reach and scale of the GoodRx platform, these programs are broadening access and affordability of crucial medications for women. New research from GoodRx shows menopause medications have increased in list price by 58% since 2014. And according to a recent study,